The 2016 accounts came 9 days late. The other nine of the last ten were filed on time.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 1,326 companies had the same profile as THALEN BIOTECH CONSULTANCY has now. Each dot stands for 4 companies, two years later.
95.1%
were still trading
3.2%
stopped another way
1.4%
went bankrupt
Micro
10 to 20 years old
solvency under 10%
a profit of 5% of the balance sheet or more
Another 0.2% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 1,326 companies, not a prediction for THALEN BIOTECH CONSULTANCY. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0607985607
Name after signing inVisible after signing in appointed as director
General meeting of 07-09-2023 · Gazette deed
Registered office moved from Rumes to Frasnes-Lez-Arivaing
The registered office moved from Rue Royale, 7611 Rumes to Bois de Martimort 7 à 7911 Frasnes-Lez-Arivaing · General meeting of 01-07-2017 · Gazette deed
Incorporation
Founding capital of €18,550, 1,200 shares, €12,400 paid up · Founded by Name hiddenVisible after signing in · Hidden nameVisible after signing in appointed as manager · published on 07-04-2015 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as THALEN BIOTECH CONSULTANCY: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €129,000 and €300,000, founded between 2014 and 2016.
What is the company number of THALEN BIOTECH CONSULTANCY?
The company number of THALEN BIOTECH CONSULTANCY is 0607.985.607. The VAT number is the same number with BE in front: BE 0607.985.607.
Where is THALEN BIOTECH CONSULTANCY based?
The registered office is at Bois de Martimont 7, 7911 Frasnes-lez-Anvaing.Company details
What does THALEN BIOTECH CONSULTANCY do?
According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of THALEN BIOTECH CONSULTANCY?
THALEN BIOTECH CONSULTANCY is a private limited company (BV).
When was THALEN BIOTECH CONSULTANCY founded?
THALEN BIOTECH CONSULTANCY was founded on 25-03-2015.
Is THALEN BIOTECH CONSULTANCY still active?
Yes, THALEN BIOTECH CONSULTANCY is an active enterprise in the KBO register.
What is the turnover of THALEN BIOTECH CONSULTANCY?
The turnover in financial year 2025 is about €550,000. This figure is estimated from the gross margin of €221,552 and 2,452 comparable companies of the same size. It probably lies between €370,000 and €850,000. It is a rough estimate.Financials
Is THALEN BIOTECH CONSULTANCY profitable?
In financial year 2025, THALEN BIOTECH CONSULTANCY made a profit of €166,089.
Where can I find the annual accounts of THALEN BIOTECH CONSULTANCY?
THALEN BIOTECH CONSULTANCY filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of THALEN BIOTECH CONSULTANCY due?
THALEN BIOTECH CONSULTANCY must file the annual accounts for financial year 2026 by 31-07-2027.Timeline